Tamaya T, Ishihara S, Motoyama T, Nioka S, Furuta N
Nihon Naibunpi Gakkai Zasshi. 1975 Dec 20;51(12):1033-42. doi: 10.1507/endocrine1927.51.12_1033.
Norethindrone (ENT), which is a representative in estrane series of progestogen, is not only strongly progestational but also estrogenic and in some cases, antiestrogenic. To understand progestational effect and antiestrogenic effect, the interactions of ENT on estrogen and progestogen receptors were studied in the uterine cytosol of white female rabbit. The 274,200 X G supernatant of uterine homogenate was used as cytosol. 3H-Estradiol, 3H-Progesterone, 3H-ENT or cold ENT were incubated with uterine cytosol at 4 degrees C for 2 hours. Results are as follows: 1. Sucrose gradient centrifugation [5 approximately 20% linear and 40,000 rpm (159,200 X G) for 16 hours at 4 degrees C]: ENT was bound to extrogen 8S receptor in immature rabbit uterus (Fig. 2 & 3), and to progestogen 8S receptor in estrogen primed rabbit uterus (Fig. 5). 2. Kinetic study, determined by dextran coated charcoal (0.001% dextran and 0.1% charcoal): (1) In the uterine cytosol of immature rabbit, 3H-estradiol-receptor binding was observed with Kd divide by 3.6 X 10-9 M and it was revealed that ENT was a competitive inhibitor to this binding with Ki divide by 2.6 X 10-6 M, as in Fig. 6. (2) 8S component, obtained by centrifugation of uterine cytosol (Fig. 1) in estrogen primed rabbit, binds 3H-progesterone with Kd divide by 8.1 X 10-10 M and Bm (maximal binding sites) divide by 5.0 X 10-8 M/mg of protein, and ENT was a competitive inhibitor in this binding with Ki divide by 2.3 X 10-9 M (FIG. 7 & 8). 3H-ENT-8S binding was demonstrated with Kd divide by 1.1 X 10-9 M and Bm divide by 8.7 X 10-8 M/mg of cytosol protein (Fig. 8). These results indicate: (a) ENT is bound to both estrogen and progestogen receptors in 8S macromolecules of uterine cytosol, (b) competitive inhibition of ENT to these bindings indicated that ENT is bound to these receptors at the steroid binding sites where estradiol and progesterone bind to, (c) ENT has much more affinity to progestogen receptor (Ki divide by 2.3 X 10-9 M) than to estrogen receptor (Ki divide 2.6 X 10-6 M), (d) while ENT is bound to progestogen and estrogen receptors at the same time, Bm of ENT (8.7 X 10-8 M/mg of cytosol protein) is more than Bm of progesterone (5.0 X 10-9 M/mg of cytosol protein), and Kd of ENT (1.1 X 10-9 M) was less than Ki of ENT (2.3 X 10-9 M) in the binding to progesterone-receptor. Biologically, while ENT is bound to progestogen -receptor with high affinity and to estrogen receptor with low affinity, ENT is actually progestational in low dose and antiestrogenic in high dose but the anti-estrogenicity seems to be incomplete in vivo as ENT may be metabolized to a potent estrogenic compound, ethinyl estradiol
炔诺酮(ENT)是孕甾烷系列孕激素的代表药物,不仅具有强烈的孕激素作用,还具有雌激素作用,在某些情况下还具有抗雌激素作用。为了解其孕激素作用和抗雌激素作用,我们在白色雌性兔的子宫胞质溶胶中研究了ENT与雌激素和孕激素受体的相互作用。子宫匀浆274,200×g的上清液用作胞质溶胶。将3H-雌二醇、3H-孕酮、3H-ENT或冷ENT与子宫胞质溶胶在4℃孵育2小时。结果如下:1.蔗糖梯度离心[5%~20%线性梯度,4℃下40,000转/分钟(159,200×g)离心16小时]:ENT与未成熟兔子宫中的雌激素8S受体结合(图2和3),并与雌激素预处理兔子宫中的孕激素8S受体结合(图5)。2.动力学研究,采用葡聚糖包被活性炭法(0.001%葡聚糖和0.1%活性炭):(1)在未成熟兔的子宫胞质溶胶中,观察到3H-雌二醇-受体结合,Kd为3.6×10-9M,结果表明ENT是该结合的竞争性抑制剂,Ki为2.6×10-6M,如图6所示。(2)在雌激素预处理兔中,通过子宫胞质溶胶离心获得的8S组分与3H-孕酮结合,Kd为8.1×10-10M,Bm(最大结合位点)为5.0×10-8M/mg蛋白质,ENT是该结合的竞争性抑制剂,Ki为2.3×10-9M(图7和8)。3H-ENT-8S结合的Kd为1.1×10-9M,Bm为8.7×10-8M/mg胞质溶胶蛋白质(图8)。这些结果表明:(a)ENT与子宫胞质溶胶8S大分子中的雌激素和孕激素受体均结合;(b)ENT对这些结合的竞争性抑制表明ENT在雌二醇和孕酮结合的类固醇结合位点与这些受体结合;(c)ENT对孕激素受体的亲和力(Ki为2.3×10-9M)远高于对雌激素受体的亲和力(Ki为2.6×10-6M);(d)虽然ENT同时与孕激素和雌激素受体结合,但ENT的Bm(8.7×10-8M/mg胞质溶胶蛋白质)高于孕酮的Bm(5.0×10-9M/mg胞质溶胶蛋白质),在与孕酮受体结合时,ENT的Kd(1.1×10-9M)小于其Ki(2.3×10-9M)。从生物学角度来看,虽然ENT与孕激素受体具有高亲和力,与雌激素受体具有低亲和力,但ENT在低剂量时实际上具有孕激素作用,在高剂量时具有抗雌激素作用,但在体内抗雌激素作用似乎不完全,因为ENT可能代谢为一种强效雌激素化合物,乙炔雌二醇